These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 18841044)
1. Application of epothilones in breast cancer therapy. Cianfrocca M Curr Opin Oncol; 2008 Nov; 20(6):634-8. PubMed ID: 18841044 [TBL] [Abstract][Full Text] [Related]
2. Ixabepilone plus capecitabine for breast cancer patients with an early metastatic relapse after adjuvant chemotherapy: two clinical trials. Fornier M Clin Breast Cancer; 2010 Oct; 10(5):352-8. PubMed ID: 20920979 [TBL] [Abstract][Full Text] [Related]
3. Activity of ixabepilone in patients with metastatic breast cancer with primary resistance to taxanes. Yardley DA Clin Breast Cancer; 2008 Dec; 8(6):487-92. PubMed ID: 19073502 [TBL] [Abstract][Full Text] [Related]
4. Clinical studies with epothilones for the treatment of metastatic breast cancer. Vahdat LT Semin Oncol; 2008 Apr; 35(2 Suppl 2):S22-30; quiz S40. PubMed ID: 18410796 [TBL] [Abstract][Full Text] [Related]
5. Ixabepilone: a novel antineoplastic agent with low susceptibility to multiple tumor resistance mechanisms. Vahdat L Oncologist; 2008 Mar; 13(3):214-21. PubMed ID: 18378531 [TBL] [Abstract][Full Text] [Related]
6. Ixabepilone, a new treatment option for metastatic breast cancer. Toppmeyer DL; Goodin S Am J Clin Oncol; 2010 Oct; 33(5):516-21. PubMed ID: 20023567 [TBL] [Abstract][Full Text] [Related]
7. Preclinical discovery of ixabepilone, a highly active antineoplastic agent. Lee FY; Borzilleri R; Fairchild CR; Kamath A; Smykla R; Kramer R; Vite G Cancer Chemother Pharmacol; 2008 Dec; 63(1):157-66. PubMed ID: 18347795 [TBL] [Abstract][Full Text] [Related]
8. Ixabepilone for the treatment of breast cancer. Alvarez RH; Valero V; Hortobagyi GN Ann Med; 2011; 43(6):477-86. PubMed ID: 21585248 [TBL] [Abstract][Full Text] [Related]
9. Clinical development of ixabepilone and other epothilones in patients with advanced solid tumors. Rivera E; Lee J; Davies A Oncologist; 2008 Dec; 13(12):1207-23. PubMed ID: 19088324 [TBL] [Abstract][Full Text] [Related]
11. The optimal therapeutic use of ixabepilone in patients with locally advanced or metastatic breast cancer. Boehnke Michaud L J Oncol Pharm Pract; 2009 Jun; 15(2):95-106. PubMed ID: 19171553 [TBL] [Abstract][Full Text] [Related]
12. Advances in breast cancer treatment: the emerging role of ixabepilone. Frye DK Expert Rev Anticancer Ther; 2010 Jan; 10(1):23-32. PubMed ID: 20014882 [TBL] [Abstract][Full Text] [Related]
13. Ixabepilone and other epothilones: microtubule-targeting agents for metastatic breast cancer. Morris PG; Fornier MN Clin Adv Hematol Oncol; 2009 Feb; 7(2):115-22. PubMed ID: 19367253 [TBL] [Abstract][Full Text] [Related]
15. Budget impact analysis of ixabepilone used according to FDA approved labeling in treatment-resistant metastatic breast cancer. Ho J; Zhang L; Todorova L; Whillans F; Corey-Lisle P; Yuan Y J Manag Care Pharm; 2009; 15(6):467-75. PubMed ID: 19610679 [TBL] [Abstract][Full Text] [Related]
16. Development of other microtubule-stabilizer families: the epothilones and their derivatives. Brogdon CF; Lee FY; Canetta RM Anticancer Drugs; 2014 May; 25(5):599-609. PubMed ID: 24398663 [TBL] [Abstract][Full Text] [Related]
17. Ixabepilone: a novel microtubule inhibitor for the treatment of locally advanced or metastatic breast cancer. Steinberg M Clin Ther; 2008 Sep; 30(9):1590-617. PubMed ID: 18840366 [TBL] [Abstract][Full Text] [Related]
18. Epothilones in breast cancer: current status and future directions. Atzori F; Fornier M Expert Rev Anticancer Ther; 2008 Aug; 8(8):1299-311. PubMed ID: 18699766 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine. Perez EA; Lerzo G; Pivot X; Thomas E; Vahdat L; Bosserman L; Viens P; Cai C; Mullaney B; Peck R; Hortobagyi GN J Clin Oncol; 2007 Aug; 25(23):3407-14. PubMed ID: 17606974 [TBL] [Abstract][Full Text] [Related]
20. Clinical experience with epothilones in patients with breast cancer. Buzdar AU Clin Breast Cancer; 2008 Mar; 8 Suppl 2():S71-8. PubMed ID: 18637402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]